Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Aug;34(6):909-15.
doi: 10.1007/s00264-009-0845-7. Epub 2009 Jul 31.

Use of Platelet-Rich Plasma for the Treatment of Refractory Jumper's Knee

Affiliations
Free PMC article
Clinical Trial

Use of Platelet-Rich Plasma for the Treatment of Refractory Jumper's Knee

Giuseppe Filardo et al. Int Orthop. .
Free PMC article

Abstract

The aim of this study was to evaluate the efficacy of multiple platelet-rich plasma (PRP) injections on the healing of chronic refractory patellar tendinopathy after previous classical treatments have failed. We treated 15 patients affected by chronic jumper's knee, who had failed previous nonsurgical or surgical treatments, with multiple PRP injections and physiotherapy. We also compared the clinical outcome with a homogeneous group of 16 patients primarily treated exclusively with the physiotherapy approach. Multiple PRP injections were performed on three occasions two weeks apart into the site of patellar tendinopathy. Tegner, EQ VAS and pain level were used for clinical evaluation before, at the end of the treatment and at six months follow-up. Complications, functional recovery and patient satisfaction were also recorded. A statistically significant improvement in all scores was observed at the end of the PRP injections in patients with chronic refractory patellar tendinopathy and a further improvement was noted at six months, after physiotherapy was added. Moreover, comparable results were obtained with respect to the less severe cases in the EQ VAS score and pain level evaluation, as in time to recover and patient satisfaction, with an even higher improvement in the sport activity level achieved in the PRP group. The clinical results are encouraging, indicating that PRP injections have the potential to promote the achievement of a satisfactory clinical outcome, even in difficult cases with chronic refractory tendinopathy after previous classical treatments have failed.

Figures

Fig. 1
Fig. 1
Comparison of the health status, evaluated with EQ-VAS, in the platelet-rich plasma (PRP) and control groups
Fig. 2
Fig. 2
Comparison of the pain level, evaluated on a 1–10 scale, in the platelet-rich plasma (PRP) and control groups
Fig. 3
Fig. 3
Comparison of the sports activity level, evaluated with the Tegner score, in the platelet-rich plasma (PRP) and control groups
Fig. 4
Fig. 4
A 22-year-old soccer player with a three year history of refractory jumper’s knee who failed both non-operative treatments and surgery. The patient returned to previous activity level after four months; MRI shows the patellar tendon before treatment (a) and the improvement of the tendon structure after the platelet-rich plasma (PRP) injections at six months’ follow-up (b)

Similar articles

See all similar articles

Cited by 62 articles

See all "Cited by" articles

Publication types

Feedback